A trio of abstracts presented at ACR Convergence 2024, the annual meeting of the American College of Rheumatology, bear out the benefits of bimekizumab (Bimzelx; UCB Pharma) for use against active ...
Colchicine fails to improve knee pain, function, or size of synovial effusions with painful knee osteoarthritis (OA), ...
Older patients with a higher comorbidity burden who have nongonococcal bacterial knee septic arthritis are at greater risk ...
Previous studies reported that cellular communication network factor 1 (CCN1) is overexpressed in the endothelial cells and synovial tissue of patients with rheumatoid arthritis (RA). French ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback